[SCHEDULE 13G/A] Cantaloupe, Inc. SEC Filing

Rhea-AI Filing Summary

Amended Schedule 13G/A filed by Abrams Capital entities and David Abrams for Cantaloupe, Inc. (CTLP) reports that none of the reporting persons beneficially owns any common stock. The filing lists each reporting person with 0 shares (0%) and discloses no sole or shared voting or dispositive power. It states the position represents ownership of 5% or less of a class and includes a certification that the securities were not acquired to change or influence control of the issuer. The filing references an Exhibit 99.1 Joint Filing Agreement.

Positive

• Clear disclosure that each reporting person beneficially owns 0 shares (0%), providing transparency to the market
• Includes reference to Exhibit 99.1 Joint Filing Agreement, documenting the reporting relationship among filers

Negative

• None.

Insights

Financial Analyst

TL;DR: Abrams group reports zero beneficial ownership in CTLP, providing no voting or dispositive power—limited investor impact.

The amended Schedule 13G/A explicitly reports 0 shares (0%) for Abrams Capital Partners II, L.P., Abrams Capital, LLC, Abrams Capital Management, LLC, Abrams Capital Management, L.P. and David Abrams. Each line shows 0 for sole and shared voting and dispositive power, so these reporting persons disclose no economic stake or control influence in Cantaloupe. For investors, the filing is a transparency disclosure with no material holdings to affect valuation or governance.

Corporate Governance Expert

TL;DR: Filing confirms a joint filing and certification that holdings are not intended to influence control; no governance concerns raised.

The document includes a certification that the securities were not acquired and are not held to change or influence control, and it references an Exhibit 99.1 Joint Filing Agreement incorporated by reference. The reporting persons formally record their status as non-owners with no voting or dispositive authority, indicating no change to board control dynamics or shareholder voting alignments based on this filing.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Cantaloupe, Inc.

(Name of Issuer)

Common Stock, no par value

(Title of Class of Securities)

138103106

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 138103106

1

Names of Reporting Persons

Abrams Capital Partners II, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 138103106

1

Names of Reporting Persons

Abrams Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 138103106

1

Names of Reporting Persons

Abrams Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 138103106

1

Names of Reporting Persons

Abrams Capital Management, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 138103106

1

Names of Reporting Persons

David Abrams

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Cantaloupe, Inc.
(b)	Address of issuer's principal executive offices: 101 Lindenwood Drive, Suite 405, Malvern, Pennsylvania 19355
Item 2.
(a)	Name of person filing: Abrams Capital Partners II, L.P. Abrams Capital, LLC Abrams Capital Management, LLC Abrams Capital Management, L.P. David Abrams
(b)	Address or principal business office or, if none, residence: c/o Abrams Capital Management, L.P. 222 Berkeley Street, 21st Floor Boston, MA 02116
(c)	Citizenship: Abrams Capital Partners II, L.P., Abrams Capital, LLC, Abrams Capital Management, LLC, Abrams Capital Management, L.P. - Delaware; David Abrams - United States
(d)	Title of class of securities: Common Stock, no par value
(e)	CUSIP No.: 138103106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Abrams Capital Partners II, L.P. - 0 shares Abrams Capital, LLC - 0 shares Abrams Capital Management, LLC - 0 shares Abrams Capital Management, L.P. - 0 shares David Abrams - 0 shares
(b)	Percent of class: Abrams Capital Partners II, L.P. - 0% Abrams Capital, LLC - 0% Abrams Capital Management, LLC - 0% Abrams Capital Management, L.P. - 0% David Abrams - 0
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Abrams Capital Partners II, L.P.- 0 shares Abrams Capital, LLC-0 shares Abrams Capital Management, LLC - 0 shares Abrams Capital Management, L.P. - 0 shares David Abrams - 0 shares
	(ii) Shared power to vote or to direct the vote: Abrams Capital Partners II, L.P. - 0 shares Abrams Capital, LLC - 0 shares Abrams Capital Management, LLC - 0 shares Abrams Capital Management, L.P. - 0 shares David Abrams - 0 shares
	(iii) Sole power to dispose or to direct the disposition of: Abrams Capital Partners II, L.P.- 0 shares Abrams Capital, LLC-0 shares Abrams Capital Management, LLC - 0 shares Abrams Capital Management, L.P. - 0 shares David Abrams - 0 shares
	(iv) Shared power to dispose or to direct the disposition of: Abrams Capital Partners II, L.P. - 0 shares Abrams Capital, LLC - 0 shares Abrams Capital Management, LLC - 0 shares Abrams Capital Management, L.P. - 0 shares David Abrams - 0 shares
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Abrams Capital Partners II, L.P.

Signature:	Abrams Capital, LLC
Name/Title:	Its General Partner
Date:	08/08/2025

Signature:	David Abrams
Name/Title:	Managing Member
Date:	08/08/2025

Abrams Capital, LLC

Signature:	David Abrams
Name/Title:	Managing Member
Date:	08/08/2025

Abrams Capital Management, LLC

Signature:	David Abrams
Name/Title:	Managing Member
Date:	08/08/2025

Abrams Capital Management, L.P.

Signature:	Abrams Capital Management, LLC
Name/Title:	Its General Partner
Date:	08/08/2025

Signature:	David Abrams
Name/Title:	Managing Member
Date:	08/08/2025

David Abrams

Signature:	David Abrams
Name/Title:	David Abrams
Date:	08/08/2025

Comments accompanying signature: Exhibits Exhibit 99.1 Joint Filing Agreement by and among the Reporting Persons, incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on January 13, 2023.

FAQ

Who filed the Schedule 13G/A for Cantaloupe (CTLP)?

The filing was made by Abrams Capital Partners II, L.P., Abrams Capital, LLC, Abrams Capital Management, LLC, Abrams Capital Management, L.P. and David Abrams.

How many Cantaloupe (CTLP) shares do the reporting persons own?

The reporting persons each report owning 0 shares, representing 0% of the class.

Do the reporting persons have voting or dispositive power over CTLP shares?

No. The filing shows 0 for sole and shared voting power and 0 for sole and shared dispositive power for each reporting person.

Does the filing indicate intent to influence control of Cantaloupe?

The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

Is there a joint filing agreement among the reporting persons?

Yes. The filing references Exhibit 99.1 (Joint Filing Agreement), incorporated by reference to a prior Schedule 13G filed on January 13, 2023.